Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
종목 코드 AMIX
회사 이름Autonomix Medical Inc
상장일Jan 29, 2024
CEOMr. Bradley (Brad) Hauser
직원 수8
유형Ordinary Share
회계 연도 종료Jan 29
주소- -
도시- -
증권 거래소NASDAQ Capital Market Consolidated
국가- -
우편 번호- -
전화- -
웹사이트- -
종목 코드 AMIX
상장일Jan 29, 2024
CEOMr. Bradley (Brad) Hauser
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음